Catalyst Wire Dossier Catalyst Wire Dossier

nisoldipine extended-release tablet

nisoldipine extended-release · Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nisoldipine extended-release tablet, covering 2008-08-08 to 2008-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg [Phase 1]

See pricing